/주식/SYRE
SYRE

SYRE

USD

Spyre Therapeutics Inc. Common Stock

$22.520+0.640 (2.925%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$21.880

고가

$22.540

저가

$21.150

거래량

0.80M

기업 기본 정보

시가총액

1.7B

산업

생명공학

국가

United States

거래 통계

평균 거래량

0.83M

거래소

NMS

통화

USD

52주 범위

저가 $10.91현재가 $22.520고가 $40.26

관련 뉴스

GlobeNewswire

Spyre Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Reported positive interim Phase 1 results for SPY003, a next-generation anti-IL-23 antibody, demonstrating the molecule was well-tolerated and exhibited an ~85-day half-life supporting quarterly or twice annual

더 보기
Spyre Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire

Spyre Therapeutics to Participate in Upcoming November Investor Conferences

WALTHAM, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ:SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of

더 보기
Spyre Therapeutics to Participate in Upcoming November Investor Conferences
GlobeNewswire

Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) Convergence 2025

WALTHAM, Mass., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ:SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of

더 보기
Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) Convergence 2025